Catalent Biologics Opens New Single-Use Biomanufacturing Center of Excellence
Tuesday, April 30, 2013
State-of-the-art cGMP facility quadruples biomanufacturing capacity, extensively utilizes single-use technology for greater flexibility and efficiency.
OPKO Health to Acquire PROLOR Biotech
Tuesday, April 30, 2013
Acquisition adds promising late stage product hGH-CTP targeting growth hormone deficiency and preclinical products targeting hemophilia, obesity & diabetes.
NIH-Developed Candidate Dengue Vaccine Shows Promise in Early-Stage Trial
Monday, April 29, 2013
The trial results appeared in the April 1 issue of the Journal of Infectious Diseases.
Batavia Bioservices and UvA Holding Announce STEP™ Technology Exclusive License
Monday, April 29, 2013
Agreement grants Batavia Bioservices the exclusive rights to STEP™ technology developed by scientists at CellaGenics BV, an UvA Holding BV company.
OBT and Boehringer Ingelheim Enter Collaboration
Monday, April 29, 2013
Collaboration to discover novel antibody targets in cancer.
Evotec expands compound management capability in the United States
Monday, April 29, 2013
Evotec (US) Inc. has executed a multi-year lease on a facility specifically designed to expand the offering of its Compound Management Services on the East Coast of the United States.
Genticel Secures EUR 18.2 Million (USD 23.7 million) in Capital Funding
Friday, April 26, 2013
Dr. Rainer Strohmenger joins the supervisory board of Genticel.
Ipsen Expects Increlex® Supply Interruption Due to Supplier Manufacturing Issues
Friday, April 26, 2013
The Group reiterates 2013 financial guidance.
Alexion Broadens and Strengthens its Executive Leadership Team
Friday, April 26, 2013
Company has expanding global mission to develop and commercialize life transforming therapies for patients with disorders that are severe, life-threatening, and ultra-rare.
|
|
|
|
|
|
